Stay updated with breaking news from Brent ogilvie. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Rare Leader: Kevin Mead, Executive Director of the International Pemphigus & Pemphigoid Foundation globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.
Pacific Channel closes $55m fund, triggers Elevate funding nbr.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nbr.co.nz Daily Mail and Mail on Sunday newspapers.
The fund has invested $500,000 into a startup developing sustainable power. Auckland-based Pacific Channel has closed its second investment, Fund II, at $55 million, exceeding the target by $5m, and triggering confirmation of $20m investment from the government-funded Elevate NZ Venture Fund. The 10-year capped fund is now the country’s largest dedicated to deep technology and hopes to invest in between 20 and 25 Kiwi companies developing cleantech, agritech, future foods, advanced engineering, and manufacturing innovation. The amount raised includes 10% from Pacific Channel management. Managing partner Brent Ogilvie said it was something they wanted to do because of the “nice return” from its first fund, and it provided skin in ....
Travellers might soon be able to test their level of Covid-19 immunity before boarding a plane. A rapid test is being developed by New Zealand-based immunity-detection company Orbis Diagnostics and French security company IDEMIA. It could be rolled out in New Zealand and Australian airports by the middle of the year. “Accurately testing whether a traveller is immune to Covid-19 will determine whether they are safe to enter their country of destination without quarantining, and without fear of infecting others, or being infected themselves,” said Orbis Diagnostics chief executive Brent Ogilvie. “Now that the world readies itself to deploy the first-generation Covid-19 vaccines, we expect immunity screening to become a crucial element of the complete solution supporting the safe resumption of international travel,” added Xavier Assouad, IDEMIA’s managing director of Oceania. ....